Description
About the Compound
BPC-157/TB-500 is a research blend combining the tissue-repair signalling of BPC-157 with the actin-binding and angiogenic activity of TB-500 (Thymosin Beta-4 fragment). It is investigated in musculoskeletal-injury and recovery research for synergistic repair and remodelling effects.
Documented Activity Profile
- Combined angiogenic and tissue-remodelling support
- Investigated for accelerated tendon, ligament and muscle recovery
- Studied for reduced inflammation in musculoskeletal models
Specifications
- 20mg per vial — lyophilized powder
- HPLC verified at 99%+ purity
- Third-party tested & COA verified per batch
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. NOT A DRUG, FOOD, OR COSMETIC. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE.

Reviews
There are no reviews yet.